Chemoinformaics analysis of Nonadecanoic acid Methyl Ester
| Molecular Weight | 312.538 | nRot | 17 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 1 |
| Exact Molecular Weight | 312.303 | nRing | 0 |
| Solubility: LogS | -6.965 | nHRing | 0 |
| Solubility: LogP | 8.462 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 61.6757 |
| nHD | 0 | BPOL | 42.7323 |
| QED | 0.218 |
| Synth | 1.757 |
| Natural Product Likeliness | 0.219 |
| NR-PPAR-gamma | 0.123 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.91 |
| MDCK | 0.0000126 |
| BBB | 0.145 |
| PPB | 0.972332 |
| VDSS | 2.917 |
| FU | 0.0135938 |
| CYP1A2-inh | 0.233 |
| CYP1A2-sub | 0.189 |
| CYP2c19-inh | 0.337 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.12 |
| CYP2c9-sub | 0.952 |
| CYP2d6-inh | 0.235 |
| CYP2d6-sub | 0.046 |
| CYP3a4-inh | 0.313 |
| CYP3a4-sub | 0.045 |
| CL | 4.701 |
| T12 | 0.171 |
| hERG | 0.331 |
| Ames | 0.006 |
| ROA | 0.02 |
| SkinSen | 0.962 |
| Carcinogencity | 0.046 |
| EI | 0.958 |
| Respiratory | 0.899 |
| NR-Aromatase | 0.046 |
| Antiviral | No |
| Prediction | 0.564918 |